PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2029

Conditions
Progressive Pulmonary FibrosisInterstitial Lung Disease
Trial Locations (13)

2050

NOT_YET_RECRUITING

Royal Prince Alfred Hospital, Camperdown

3000

NOT_YET_RECRUITING

Austin Health, Melbourne

4032

NOT_YET_RECRUITING

Prince Charles Hospital, Brisbane

22908

NOT_YET_RECRUITING

University of Virginia, Charlottesville

48109

RECRUITING

University of Michigan, Ann Arbor

75390

NOT_YET_RECRUITING

University of Texas Southwestern, Dallas

98195

NOT_YET_RECRUITING

University of Washington, Seattle

01655

RECRUITING

University of Massachusetts Chan Medical School, Worcester

T2N 4Z6

NOT_YET_RECRUITING

University of Calgary, Calgary

V6Z 1Y6

NOT_YET_RECRUITING

University of British Columbia, Vancouver

D04 T6F4

NOT_YET_RECRUITING

University College Dublin, Dublin

SW3 6NP

NOT_YET_RECRUITING

Royal Brompton, London

SO16 7DL

NOT_YET_RECRUITING

University Hospital Southampton, Southampton

All Listed Sponsors
collaborator

University of Michigan

OTHER

collaborator

University of Virginia

OTHER

collaborator

Johannes Gutenberg University Mainz

OTHER

collaborator

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

lead

University of Massachusetts, Worcester

OTHER